SEC Filing Details
Document Details
Form
Filing Date
Feb 23, 2021
Document Date
Feb 23, 2021
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
BioLineRx
Issuer
BioLineRx Ltd.
Press Releases View all
March 22, 2023
BioLineRx Reports 2022 Financial Results and Recent Corporate and Portfolio Updates
March 15, 2023
BioLineRx to Report 2022 Annual Financial Results on March 22, 2023